MindMaze Therapeutics Holding S.A. (RLFTF)
MindMaze Therapeutics Holding S.A. operates in the Biotechnology industry of the Healthcare sector, headquartered in Geneva, GE, CH. The stock last traded at $0.24, down 21.24% on the session, giving a market capitalisation of $3.0M. Its beta of 1.23 implies it has historically moved more than the broad market.
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
MindMaze Therapeutics Holding S.A. is most often compared with the following Healthcare names: